Health Care • Hospital/Nursing Management
$202.09 ▼ -4.05
(-1.96%)
MKT CAP: $3.23B • VOL: 165.2K
52W L $118 52W H $248
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$170
MEDIAN
$226
MEAN
$230
HIGH
$275
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE NHC TAPE
NHC // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $244.53 | $232.40 | 2025-02-14 | $183.90 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $254.63 | $238.47 | 2025-02-06 | $189.96 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $230.38 | $222.30 | 2025-01-29 | $194.01 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $206.13 | — | 2025-01-17 | $198.05 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $177.84 | $191.99 | 2025-01-09 | $179.86 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $240.49 | $210.17 | 2024-12-18 | $175.82 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $196.03 | $204.11 | 2024-12-04 | $187.94 | -4.3% | 48% | C |